Chair: I welcome our panelists. We all know how severe this issue is – medicines are unavailable or unaffordable. This is for a variety of reasons, some of it is regulatory – lets not forget that there is a lot of weork done to optimize legislation. There is also often a lack of professional knowledge. …
Japan
CND thematic sessions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration – 21 September 2022
Multiyear Workplan 2019-2023: Implementation of all our international drug policy commitments, following up to the 2019 ministerial declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of our Joint Commitments to Address and Counter the World Drug Problem” The provisional agenda for the intersessional meeting is as follows: 1. Thematic …
Committee of the Whole L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs
Secretariat: There will be an informal on L5 in a hybrid format on BR-A. L7 – Technical amendment. On OP12 & 13 – There is in square brackets ‘or trafficking’. There was an omission to delete this part. Just checking with the CoW. Ok, we can continue. United States: We engaged in consultations, not in …
Committee of the Whole L5 Promoting comprehensive and scientific evidence-based early prevention
Chair: We still have a lot of work to do – I hope you’ve had a decent rest and that we can make some progress. Slovenia: Para on gender in OP5 & OP9. Alternative para by Egypt – we are close to consensus. Apparently OP9 is too general. We propose delete end of OP5, keep …
Side event: International Standards for Reporting Cannabis and Cannabis-related Substances for Medical Purposes
18 March 2022 at 8:00 AM- 8:50 AM Vienna Time (CET) Organised by the INCB Narcotic Control and Estimates Section with the support of Argentina, Australia, Costa Rica, Israel, Germany, Japan, the Netherlands, Paraguay, Portugal, South Africa, Spain, Switzerland, the United Kingdom, the United States, and the African Union Commission, the European Union and the …
Committee of the Whole Resolution L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs (evening session)
Chair: Can the US introduce to us what are the agreements that you could reach during the informal consultations? USA: thank you Sir. I think we’ve had an extensive discussion on the title, and I think we’re pretty close. We have some new flexibility that we want to offer so I might turn it to …